The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

(2011) Galia Spectre et al.   THROMBOSIS AND HAEMOSTASIS

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

(2010) Michael Pignone et al.   CIRCULATION

Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes

(2010) Faouzi Addad et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Aspirin Resistance Is Associated with Glycemic Control, the Dose of Aspirin, and Obesity in Type 2 Diabetes Mellitus

(2010) Derun Taner Ertugrul et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events

(2010) N. J. BREET et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus

(2010) F. SANTILLI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays

(2009) Francesca Santilli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aspirin ‘resistance’: role of pre-existent platelet reactivity and correlation between tests

(2008) A. L. FRELINGER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Diabetes and aspirin: beware of underpowered negative trials

(2008) Michael E Farkouh et al.   Nature clinical practice. Cardiovascular medicine